SBIR/STTR Research Award

Biological vector control reducing arboviruses, including Dengue and Chikungunya

Award identifier 2068c8dc01ccbbe4ebf46376e83dc1185dbc6333f399153e86a79896ef7b1c8cAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,799,495

Program and phase

SBIR · Phase II

Award year

2014

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
MosquitoMate, Inc
Proposal award date
2014-06-01
Contract end date
2018-05-31
UEI
F873ZJEX7615
Solicitation number
PA14-077
Topic code
NIAID

Research abstract

DESCRIPTION provided by applicant In the absence of effective approved drugs or vaccines vector control remains the only means of intervention for many against mosquito borne diseases This problem grows more complex with the recent establishment of multiple exotic mosquito species and mosquito borne pathogens Furthermore changing climate conditions are predicted to alter the traditional range for native mosquitoes A notable example is Aedes albopictus the Asian Tiger mosquito introduced into the USA in the mid s this invasive species has spread throughout the southeast and with warmer winters its range is now moving into New York and other northern states where it has become the primary biting mosquito A stable infestation was discovered in California in which persists despite an ongoing elimination campaign The cryptic biology of this mosquito makes it difficult to find and treat using traditional insecticidal approaches In addition to its importance as a biting nuisance A albopictus is a competent vector of over twenty pathogens Epidemiological models show risk of returning travelers infected with chikungunya virus infecting A albopictus and starting local transmission This hypothesized event would be similar to recent epidemics that have occurred in Europe India Sri Lanka and La Reunion Our discussions with major mosquito control districts around the country California Florida New York demonstrate the need and commercial opportunity for new approaches against A albopictus and an interest in the our product Our Phase I results demonstrate feasibility of a Wolbachia biopesticide approach Repeated releases of Wolbachia infected males cause a form of conditional sterility capable of eliminating an A albopictus population within eight weeks In the proposed Phase II work we will continue the research and development of the Wolbachia biopesticide approach with the major goals of demonstrating a prototype mass production unit providing field performance data for Wolbachia infected A albopictus males and measuring the pesticidal effect of Wolbachia infected A albopictus males against an indigenous field population PUBLIC HEALTH RELEVANCE Effective control tools are needed against the invasive disease vector mosquito Aedes albopictus Asian Tiger mosquito Contained trials in Phase I have shown that the repeated release of males infected with Wolbachia bacteria can cause sterility and eliminate A albopictus populations The proposed Phase II work will demonstrate efficacy of the control approach in the field against an established population and improve product production to improve the overall production levels and reduce downstream cost

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

5 SBIR/STTR records share this UEI (2012–2020). Reported award amounts total $4,141,510. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.